Showing 1 - 19 results of 19 for search 'T. A. Deeva', query time: 0.03s Refine Results
  1. 1
    Development of the optimal scheme for the synthesis of the dipeptide TSPO ligand, N-phenylpropionyl-L-tryptophanyl-L-leucine amide (GD-102), a potential anxiolytic drug

    Development of the optimal scheme for the synthesis of the dipeptide TSPO ligand, N-phenylpropionyl-L-tryptophanyl-L-leucine amide (GD-102), a potential anxiolytic drug by O. A. Deeva

    Published 2024-01-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    PROGNOSTIC SIGNIFICANCE OF GALECTIN-3 MEASUREMENT IN PATIENTS WITH METABOLIC SYNDROME AND NON-ALCOHOLIC FATTY LIVER DISEASE

    PROGNOSTIC SIGNIFICANCE OF GALECTIN-3 MEASUREMENT IN PATIENTS WITH METABOLIC SYNDROME AND NON-ALCOHOLIC FATTY LIVER DISEASE by O. M. Drapkina, T. A. Deeva

    Published 2015-10-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    GALECTIN-3 — BIOMARKER OF FIBROSIS IN PATIENTS WITH METABOLIC SYNDROME

    GALECTIN-3 — BIOMARKER OF FIBROSIS IN PATIENTS WITH METABOLIC SYNDROME by O. M. Drapkina, T. A. Deeva

    Published 2015-09-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Methods оf Expert Evaluations in Applied Information Economics for the Analysis оf Efficiency Investments in Development of Information Systems

    Methods оf Expert Evaluations in Applied Information Economics for the Analysis оf Efficiency Investments in Development of Information Systems by E. V. Vasileva, E. A. Deeva

    Published 2018-04-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Correction of Thrombocytopenia with Thrombopoietin Receptor Agonists in Patients with Liver Cirrhosis Before Elective Surgery or Invasive Procedures

    Correction of Thrombocytopenia with Thrombopoietin Receptor Agonists in Patients with Liver Cirrhosis Before Elective Surgery or Invasive Procedures by T. A. Deeva, M. V. Maevskaya, V. T. Ivashkin

    Published 2025-02-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    EVALUATION OF LEPTIN SERUM LEVELS IN PATIENTS WITH METABOLIC SYNDROME AND LEFT VENTRICULAR MYOCARDIAL HYPERTROPHY

    EVALUATION OF LEPTIN SERUM LEVELS IN PATIENTS WITH METABOLIC SYNDROME AND LEFT VENTRICULAR MYOCARDIAL HYPERTROPHY by O. M. Drapkina, R. N. Shepel, T. A. Deeva

    Published 2018-03-01
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    PROGNOSTIC SIGNIFICANCE OF GALECTIN-3 LEVEL ASSESSMENT IN METABOLIC SYNDROME PATIENTS WITH HEART FAILURE

    PROGNOSTIC SIGNIFICANCE OF GALECTIN-3 LEVEL ASSESSMENT IN METABOLIC SYNDROME PATIENTS WITH HEART FAILURE by O. M. Drapkina, R. N. Shepel, T. A. Deeva

    Published 2017-12-01
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Epicardial fat as a new early marker of cardiovascular disease in patients with non-alcoholic fatty liver disease

    Epicardial fat as a new early marker of cardiovascular disease in patients with non-alcoholic fatty liver disease by O. M. Drapkina, O. N. Korneeva, T. A. Deeva

    Published 2014-06-01
    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    PLASMA LEPTIN LEVELS IN METABOLIC SYNDROME PATIENTS WITH ISCHEMIC HEART DISEASE

    PLASMA LEPTIN LEVELS IN METABOLIC SYNDROME PATIENTS WITH ISCHEMIC HEART DISEASE by O. M. Drapkina, R. N. Shepel, T. A. Deeva

    Published 2016-06-01
    Get full text
    Article
    Save to List
    Saved in:
  10. 10
    GALECTIN-3 LEVEL IN pATIENTS WITH mETAbOLIC SYNDROmE AND CORONARY HEART DISEASE

    GALECTIN-3 LEVEL IN pATIENTS WITH mETAbOLIC SYNDROmE AND CORONARY HEART DISEASE by O. М. Drapkina, R. N. Shepel, Т. A. Deeva

    Published 2017-03-01
    Get full text
    Article
    Save to List
    Saved in:
  11. 11
    Transient deficiency of protein S after past infection process, complications and outcome: clinical case

    Transient deficiency of protein S after past infection process, complications and outcome: clinical case by Olga B. Gordeeva, Albina V. Dobrotok, Liliia R. Selimzianova, Valeria A. Deeva

    Published 2023-03-01
    Get full text
    Article
    Save to List
    Saved in:
  12. 12
    Translocator protein TSPO 18 kDa and its ligands: a promising approach to the creation of new neuropsychotropic drug

    Translocator protein TSPO 18 kDa and its ligands: a promising approach to the creation of new neuropsychotropic drug by G. V. Mokrov, O. A. Deeva, M. A. Yarkova, T. A. Gudasheva, S. B. Seredenin

    Published 2018-11-01
    Get full text
    Article
    Save to List
    Saved in:
  13. 13
    Study of anxiolytic activity and possible side effects of the dipeptide ligand of the translocator protein TSPO — compound GD-102 in a wide range of doses in behavioral experiments using rats and mice

    Study of anxiolytic activity and possible side effects of the dipeptide ligand of the translocator protein TSPO — compound GD-102 in a wide range of doses in behavioral experiments... by S. O. Kotel'nikova, O. A. Deeva, V. A. Kraineva, T. A. Gudasheva, T. A. Voronina, V. L. Dorofeev

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:
  14. 14
    Diagnosis and Treatment Challenges of Niemann – Pick Disease, Type B: Clinical Case

    Diagnosis and Treatment Challenges of Niemann – Pick Disease, Type B: Clinical Case by Diana V. Golygina, Aikhee K.-D. Begzy, Viktoriya A. Deeva, Natalya N. Borovik, Vladimir A. Shcherbak

    Published 2025-02-01
    Get full text
    Article
    Save to List
    Saved in:
  15. 15
    The effect of processing conditions on the dielectric properties of doped calcium lanthanum nickelate

    The effect of processing conditions on the dielectric properties of doped calcium lanthanum nickelate by Yulia A. Deeva, Abdullo A. Mirzorakhimov, Alexey Yu. Suntsov, Nadezhda I. Kadyrova, Nina V. Melnikova, Tatyana I. Chupakhina

    Published 2022-08-01
    Get full text
    Article
    Save to List
    Saved in:
  16. 16
    Solid Sr2Ti1-xMnxO4 (x = 0; 0,01; 0,025; 0,05; 0,1) solutions with K2NiF4 structure

    Solid Sr2Ti1-xMnxO4 (x = 0; 0,01; 0,025; 0,05; 0,1) solutions with K2NiF4 structure by T.I. Chupakhina, A.M. Uporova, O.I. Gyrdashova, L.Yu. Buldakova, Y.A. Deeva, I.V. Baklanova, M.Yu. Yanchenko

    Published 2024-12-01
    Get full text
    Article
    Save to List
    Saved in:
  17. 17
    Steatotic Liver Disease: New Nomenclature and Its Localization in the Russian Federation

    Steatotic Liver Disease: New Nomenclature and Its Localization in the Russian Federation by K. L. Raikhelson, M. V. Maevskaya, M. S. Zharkova, V. R. Grechishnikova, S. V. Okovityi, T. A. Deeva, N. V. Marchenko, M. К. Prashnova, V. T. Ivashkin

    Published 2024-05-01
    Get full text
    Article
    Save to List
    Saved in:
  18. 18
    Clinical Recommendations of the Russian Scientific Liver Society and Russian Gastroenterological Association on Diagnosis and Treatment of Liver Fibrosis, Cirrhosis and Their Complications

    Clinical Recommendations of the Russian Scientific Liver Society and Russian Gastroenterological Association on Diagnosis and Treatment of Liver Fibrosis, Cirrhosis and Their Compl... by V. T. Ivashkin, M. V. Maevskaya, M. S. Zharkova, S. B. Zhigalova, E. A. Kitsenko, G. V. Manukyan, A. S. Trukhmanov, I. V. Maev, I. N. Tikhonov, T. A. Deeva

    Published 2022-03-01
    Get full text
    Article
    Save to List
    Saved in:
  19. 19
    Correction of Thrombocytopenia before Elective Surgery / Invasive Procedures in Patients with Liver Cirrhosis (Experts’ Agreement)

    Correction of Thrombocytopenia before Elective Surgery / Invasive Procedures in Patients with Liver Cirrhosis (Experts’ Agreement) by M. V. Maevskaya, M. Yu. Nadinskaia, E. N. Bessonova, N. I. Geyvandova, M. S. Zharkova, E. A. Kitsenko, N. V. Korochanskaya, I. A. Kurkina, A. L. Melikyan, V. G. Morozov, Yu. V. Khoronko, T. A. Deeva, K. A. Gulyaeva, V. T. Ivashkin

    Published 2024-08-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: